Didier Lapierre

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

Daniel E. Neafsey, Michal Juraska, Trevor Bedford et al. · New England Journal of Medicine · 2015 · 451 citations · Full text

Veterinary Medicine, Genetics, Infectious Diseases +14

Risk of Myocardial Infarction and Abacavir Therapy: No Increased Risk Across 52 GlaxoSmithKline-Sponsored Clinical Trials in Adult Subjects

Cindy Brothers, Jaime E. Hernández, Amy Cutrell et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2009 · 182 citations

Medicine, Cardiology, Pharmacology +15

Efficacy of RTS,S/AS01E malaria vaccine and exploratory analysis on anti-circumsporozoite antibody titres and protection in children aged 5–17 months in Kenya and Tanzania: a randomised controlled trial

Ally Olotu, John Lusingu, Amanda Leach et al. · The Lancet Infectious Diseases · 2011 · 170 citations

Medicine, Infectious Diseases, Pediatrics +14

Safety and immunogenicity of candidate vaccine M72/AS01E in adolescents in a TB endemic setting

Adam Penn‐Nicholson, Hennie Geldenhuys, Wivine Burny et al. · Vaccine · 2015 · 142 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Safety and efficacy of the RTS,S/AS01E candidate malaria vaccine given with expanded-programme-on-immunisation vaccines: 19 month follow-up of a randomised, open-label, phase 2 trial

Kwaku Poku Asante, Salim Abdulla, Sélidji Todagbé Agnandji et al. · The Lancet Infectious Diseases · 2011 · 136 citations

Veterinary Medicine, Immunology, Infectious Diseases +11